OCPNF:OTC-Olympus Corporation (USD)

COMMON STOCK | Medical Instruments & Supplies |

Last Closing

USD 14.04

Change

-0.56 (-3.84)%

Market Cap

USD 17.15B

Volume

109.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-17 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
ESLOY Essilor International SA

-0.72 (-0.66%)

USD 98.67B
ESLOF EssilorLuxottica Société ano..

-1.12 (-0.52%)

USD 97.51B
HOCPY Hoya Corp

+2.09 (+1.79%)

USD 41.31B
HOCPF HOYA Corporation

+3.00 (+2.69%)

USD 41.31B
CLPBY Coloplast A

+0.04 (+0.34%)

USD 29.16B
SRTOY Sartorius Stedim Biotech S.A

+0.72 (+3.12%)

USD 28.34B
RSMDF Resmed Inc DRC

N/A

USD 28.04B
CLPBF Coloplast A/S

N/A

USD 26.54B
TRUMF Terumo Corporation

+0.17 (+1.04%)

USD 24.91B
TRUMY Terumo Corp ADR

+0.26 (+1.57%)

USD 24.77B

ETFs Containing OCPNF

REMX VanEck Rare Earth/Strateg.. 5.33 % 0.59 %

+2.22 (+0%)

USD 0.33B
XME SPDR® S&P Metals and Min.. 4.59 % 0.35 %

+0.54 (+0%)

USD 2.04B
PBW Invesco WilderHill Clean .. 1.94 % 0.70 %

+0.54 (+0%)

USD 0.30B
SPXZ 1.50 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.97% 53% F 47% F
Dividend Return 0.92% 50% F 24% F
Total Return -2.05% 50% F 47% F
Trailing 12 Months  
Capital Gain -23.98% 32% F 41% F
Dividend Return 0.72% 34% F 26% F
Total Return -23.27% 29% F 40% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 5.20% 46% F 49% F
Dividend Return 5.36% 43% F 45% F
Total Return 0.16% 56% F 6% D-
Risk Return Profile  
Volatility (Standard Deviation) 26.03% 81% B- 78% C+
Risk Adjusted Return 20.60% 59% D- 55% F
Market Capitalization 17.15B 77% C+ 93% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.